High Levels of Orexin A in the Brain of the Mouse Model for Phenylketonuria: Possible Role of Orexin A in Hyperactivity Seen in Children with PKU

Neurochemical Research

Volumn 28, Issue 12, 2003, Pages 1891-1894

  Surendran, Sankar ^a   Campbell, Gerald A ^a   Tyring, Stephen K ^a   Matalon, Kimberlee ^a   McDonald, J David ^b   Matalon, Reuben ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b WICHITA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Hyperactivity; Hypocretin 1; Mouse brain; Orexin A; Phenylketonuria

Indexed keywords

OREXIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN LEVEL; BRAIN REGION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; HEART; HYPERACTIVITY; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; STAINING; TISSUE LEVEL; WILD TYPE;

ANIMALS; BRAIN; CARRIER PROTEINS; CHILD; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MOTOR ACTIVITY; NEUROPEPTIDES; PHENYLKETONURIAS; RADIOIMMUNOASSAY;

ANIMALIA;

EID: 0345255662     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026184127689     Document Type: Article

References (28)

1. Folling, A. 1934. Uber Ausscheidung von phenylbrenztraubensaure in den Harn als Stoffwechselanomalie in verbingdung mit imbezillitat. Hoppe-Seylers Z. Physiol. Chem. 227:169-176.
2. Penrose, L. S. 1935. Inheritance of phenylpyruvic amenta (phenylketonuria). Lancet 2:192-194.
3. Kaufman, S. and Fisher, D. B. 1974. Pterin-requiring aromatic acid hydroxylases, Pages 285-369, in Hayaishi, O. (ed.), Molecular mechanisms of oxygen activation. Academic press, New York.
4. Lenke, R. R. and Levy, H. L. 1994. Maternal phenylketonuria and hyperphenylalaninemias of man and mouse. Ann. Rev. Genet. 303:1202-1208.
5. Rouse, B., Lockhart, L., Matalon, R., Azen, C., Koch, R., Hanley, W., Levy, H., Dela Cruz, F., and Friedman, E. 1990. Maternal phenylketonuria pregnancy outcome: A preliminary report of facial dysmorphology and major malformations. J. Inher. Metab. Dis. 13:289-291.
6. Cowie, V. A. 1971. Neurological and psychiatric aspects of phenylketonuria. Pages 29-39, in Bickel, H., Hudson, F. P., and Woolf, L. I. (eds.), Phenylketonuria and some other inborn errors of aminoacid metabolism, George Thieme Verlag, Stuttgart.
7. Hendrikx, M. M. T., van der Schot, L. W. A., Slijper, F. M. E., Huisman, J., and Kalverboer, A. F. 1994. Phenylketonuria and some aspects of emotional development. Eur. J. Pediatr. 153:832-835.
8. Kalverboer, A. F., van der Schot, L. W. A., Hendrikx, M. M. T., Huiman, J., Slijper, F. M. E., and Stemerdink, B. A. 1994. Social behavior and task orientation in early treated PKU. Acta Paediatr. 83(S407):104-105.
9. Realmuto, G. M., Garfinkel, B. D., Tuchman, M., Tsai, M. Y., Chang, P. N., Pisch, R. O., and Shapiro, S. 1986. Psychiatric diagnosis and behavioral characteristics of phenylketonuric children. J. Nerv. Ment. Dis. 174:536-540.
10. McDonald, J. D., Dyer, C. A., Gailis, L., and Kirby, M. 1997. Cardiovascular defects among the progeny of mouse phenylketonuria females. Pediatr. Res. 42:103-107.
11. de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L., Gautvig, B. T., Barlett, F. S., Frankel, W. N., van den Pol, A. N., Bloom, F. E., Gautvik, K. M., and Sutkliff J. G. 1998. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 95:322-327.
12. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richarson, J. A., Koslowski. G. P., Wilson, S., Arch, J. R., Buckingham, R. E., Haynes, A. C., Carr, S. A., Annan, R. S., McNulty, D. E., Liu, W. S., Terrett, J. A., Elshourbagy, N. A., Bergsma, D. J., and Yanagisawa, M. 1998. Orexins and orexin receptors: A family of hypothalamus neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585.
13. Peyron, C., Tighe, D. K., van den pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., and Kilduff, T. S. 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:9996-10015.
14. Nambu, T., Sakurai, T., Mizukami, K., Hosoy, Y., Yanagisawa, M., and Goto, K. 1999. Distribution of orexin neurons in the adult rat brain. Brain Res. 827:243-260.
15. van den Pol, A. N. 1999. Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord. J. Neurosci. 19:3171-3182.
16. Samson, W. K., Gosnell, B., Chang, J., Resch, Z. T., and Murphy, T. C. 1999. Cardiovascular regulatory action of hypocretins in brain. Brain Res. 831:248-253.
17. Shirasaka, T., Takasaki, M., and Kannan, H. 2003. Cardiovascular effects of leptin and orexins. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:R639-R651.
18. Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., Benhams, C. D., Tayler, S. G., Routledge, C., Hemmati, P., Munton, R. P., Ashmede, T. E., Shah, A. S., Hatcher, J. P., Hatcher, P. D., Jones, D. E., Smith, M. I., Piper, D. C., Hunter, A. J., Porter, R. A., and Upton, N. 1999. Orexin activates locus coeruleus cell firing and increases arousal in the rats. Proc. Natl. Acad. Sci. USA 96:10911-10916.
19. Ida, T., Nakahara, K., Katayama, N., Murakami, N., and Nakazato, M. 1999. Effect of lateral cerebroventricular injection of the appetite stimulating neuropeptide, orexin and neuropeptide Y on the various behavioral activities of rats. Brain Res. 821:526-529.
20. Taylor, M. M. and Samson, W. K. 2003. The other side of the orexins: Endocrine and metabolic actions. Am. J. Physiol. Endocrinol. Metab. 284:E13-E17.
21. Matalon, R., Rady, P. L., Platt, K. A., Skinner, H. B., Quast, M. J., Campbell, G. A., Matalon, K., Ceci, J. D., Tyring, S. K., Nehls, M., Surendran, S., Wei, J., Ezell, E. L. and Szucs, S. 2000. Knock out mouse for Canavan disease: A mouse model for gene transfer to the central nervous system. J. Gene Med. 2:165-175.
22. Kurose, T., Ueta, Y., Yamamoto, Y., Serino, R., Ozaki, Y., Saito, J., Nagata, S., and Yamashita, H. 2002. Effects of restricted feeding on the activity of hypothalamic orexin (OX)-A containing neurons and OX2 receptor mRNA level in the paraventricular nucleus of rats. Regul. Peptides 104:145-151.
23. Pitt, D. B. and Danks, D. M. 1991. The natural history of untreated phenylketonuria over 20 years. J. Pediatr. Child Health 27:189-190.
24. van der Knapp, M. S. and Valk, J. 1995. Magnetic resonance of myelin, myelination and myelin disorders. Springer, New York.
25. Matalon, R., Surendran, S., Michals-Matalon, K., Quast, M., Wei, J., Ezell, E., and Szucs, S. 2003. Future role of large neutral amino-acids in the transport of phenylalanine into the brain. Pediatrics (in press).
26. Taheri, S., Mahmoodi, M., Opacka-Juffry, J., Ghatei, M. A. and Bloom, S. R. 1999. Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Lett. 457:157-161.
27. Shirasaka, T., Miyahara, S., Kunitake, T., Jin, Q. H., Kato, K., Takasaki, M., and Kannan, H. 1999. Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 277:R1780-R1785.
28. Matsumura, K., Tsuchihashi, T., and Abe, I. 2001. Central orexin A augments sympathoadrenal outflow in conscious rabbits. Hypertension 3:1382-1387.